German China India

Bayer/Algeta Takeover

Bayer Announces Takeover of Algeta of Norway

| Editor: Dominik Stephan

Bayer reseach facility in Berlin. The company boost its healthcare business with the acquisition of Algeta of Norway.
Bayer reseach facility in Berlin. The company boost its healthcare business with the acquisition of Algeta of Norway. (Picture: Bayer)

Bayer' takeover offer for Algeta was successful: The German chemical company will acquire the Norwegian pharma specialist for approximately € 1.9 billion. Both companies had already cooperated on the development of cancer drugs.

Leverkusen/Germany; Oslo/Norway – All regulatory approvals required have been obtained, so that transfer and payment can be finalised before March 12th. "This transaction will strengthen our oncology business and support our efforts to provide patients with innovative treatment options. We plan to work together with the Algeta team to leverage the full value of this business", said Olivier Brandicourt, CEO of Bayer Health Care. Bayer and Algeta have been collaborating since 2009 to develop and commercialize radium-223 dichloride, which was approved in the United States in May 2013 under the tradename Xofigo.

Bayer's Acquisition of Algeta of Norway Takes Next Step

Bayer Acquires Algeta

Bayer's Acquisition of Algeta of Norway Takes Next Step

21/01/2014 - Bayer strengthens its position in the tumor treatments market: The chemical giant's plans to take over Norwegian company Algeta take the next step, as Bayer issued a takeover offer for all Algeta shares. read...

“We have already successfully collaborated with Algeta to develop and commercialize the cancer drug Xofigo“, commented Bayer CEO Dr. Marijn Dekkers. “The acquisition gives us full control over Xofigo™. We are absolutely convinced of the potential of this drug and the underlying technology to provide patients with innovative treatment options.”

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 42551269 / Business & Economics)